Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Dev Cell ; 56(20): 2790-2807.e8, 2021 10 25.
Article in English | MEDLINE | ID: covidwho-1446559

ABSTRACT

SARS-CoV-2 virions are surrounded by a lipid bilayer that contains membrane proteins such as spike, responsible for target-cell binding and virus fusion. We found that during SARS-CoV-2 infection, spike becomes lipid modified, through the sequential action of the S-acyltransferases ZDHHC20 and 9. Particularly striking is the rapid acylation of spike on 10 cytosolic cysteines within the ER and Golgi. Using a combination of computational, lipidomics, and biochemical approaches, we show that this massive lipidation controls spike biogenesis and degradation, and drives the formation of localized ordered cholesterol and sphingolipid-rich lipid nanodomains in the early Golgi, where viral budding occurs. Finally, S-acylation of spike allows the formation of viruses with enhanced fusion capacity. Our study points toward S-acylating enzymes and lipid biosynthesis enzymes as novel therapeutic anti-viral targets.


Subject(s)
Acylation/physiology , COVID-19 Drug Treatment , Membrane Lipids/metabolism , SARS-CoV-2/pathogenicity , Acyltransferases/metabolism , Golgi Apparatus/metabolism , Golgi Apparatus/virology , Humans , Virus Assembly/physiology
SELECTION OF CITATIONS
SEARCH DETAIL